Lactobacillus casei ATCC 393 and it's metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)/IL-1β pathway - PubMed (original) (raw)
. 2021 Nov 29;12(23):12022-12035.
doi: 10.1039/d1fo02405a.
Affiliations
- PMID: 34755743
- DOI: 10.1039/d1fo02405a
Lactobacillus casei ATCC 393 and it's metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)/IL-1β pathway
Xina Dou et al. Food Funct. 2021.
Abstract
Inflammatory bowel disease (IBD) represents a broad group of intestinal disorders, including ulcerative colitis (UC) and Crohn's disease (CD). Probiotics are increasingly being recognized as a means of treatment for people suffering from IBD. Our previous studies demonstrated that Lactobacillus casei ATCC 393 (L. casei ATCC 393) effectively alleviated enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction. This study was conducted to investigate the protective effects of L. casei ATCC 393 and its metabolites on dextran sulfate sodium (DSS)-induced UC in C57BL/6 mice and the potential mechanism of these effects. The results showed that oral administration of L. casei ATCC 393 and its metabolites both effectively reversed the DSS-induced weight loss, and the reduction in the disease activity index (DAI), colon length, and villus height of colon tissue in mice. Compared to the DSS-induced model group, L. casei ATCC 393 and its metabolites significantly inhibited the infiltration of immune cells into the intestinal mucosa, decreased the production of pro-inflammatory factors, and increased the expression of anti-inflammatory factors in the serum and colon tissue, increased the expression levels of occludin, ZO-1, and claudin-1, and reduced the expression of nucleotide binding oligomeric domain-like receptor protein 3 (NLRP3), cysteine proteinase-1 (Caspase-1), IL-1β, and IL-18. In addition, L. casei ATCC 393 and its metabolites effectively improved DSS-induced gut microbiota dysbiosis. These results suggested that L. casei ATCC 393 and its metabolites alleviated the DSS-induced ulcerative inflammatory response in C57BL/6 mice through the NLRP3-(Caspase-1)/IL-1β signaling pathway.
Similar articles
- Lactobacillus casei ATCC 393 combined with vasoactive intestinal peptide alleviates dextran sodium sulfate-induced ulcerative colitis in C57BL/6 mice via NF-κB and Nrf2 signaling pathways.
Zhu L, Qiao L, Dou X, Song X, Chang J, Zeng X, Xu C. Zhu L, et al. Biomed Pharmacother. 2023 Sep;165:115033. doi: 10.1016/j.biopha.2023.115033. Epub 2023 Jun 26. Biomed Pharmacother. 2023. PMID: 37379640 - Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation.
Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Qu S, et al. Microbiol Spectr. 2021 Oct 31;9(2):e0073021. doi: 10.1128/Spectrum.00730-21. Epub 2021 Oct 6. Microbiol Spectr. 2021. PMID: 34612661 Free PMC article. - Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice.
Li X, Wu X, Wang Q, Xu W, Zhao Q, Xu N, Hu X, Ye Z, Yu S, Liu J, He X, Shi F, Zhang Q, Li W. Li X, et al. Phytomedicine. 2022 Sep;104:154321. doi: 10.1016/j.phymed.2022.154321. Epub 2022 Jul 9. Phytomedicine. 2022. PMID: 35843190 - Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review.
Direito R, Barbalho SM, Figueira ME, Minniti G, de Carvalho GM, de Oliveira Zanuso B, de Oliveira Dos Santos AR, de Góes Corrêa N, Rodrigues VD, de Alvares Goulart R, Guiguer EL, Araújo AC, Bosso H, Fornari Laurindo L. Direito R, et al. Metabolites. 2023 Jun 6;13(6):728. doi: 10.3390/metabo13060728. Metabolites. 2023. PMID: 37367886 Free PMC article. Review. - Lactocepin as a protective microbial structure in the context of IBD.
Hörmannsperger G, von Schillde MA, Haller D. Hörmannsperger G, et al. Gut Microbes. 2013 Mar-Apr;4(2):152-7. doi: 10.4161/gmic.23444. Epub 2013 Jan 18. Gut Microbes. 2013. PMID: 23333860 Free PMC article. Review.
Cited by
- Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model.
Zhang T, Zhang W, Feng C, Kwok LY, He Q, Sun Z. Zhang T, et al. NPJ Sci Food. 2022 Nov 15;6(1):53. doi: 10.1038/s41538-022-00169-9. NPJ Sci Food. 2022. PMID: 36379940 Free PMC article. - Lactic Acid Bacteria-Gut-Microbiota-Mediated Intervention towards Inflammatory Bowel Disease.
Li D, Liu Z, Fan X, Zhao T, Wen D, Huang X, Li B. Li D, et al. Microorganisms. 2024 Sep 9;12(9):1864. doi: 10.3390/microorganisms12091864. Microorganisms. 2024. PMID: 39338538 Free PMC article. Review. - Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction.
Yan M, Hou L, Cai Y, Wang H, Ma Y, Geng Q, Jiang W, Tang W. Yan M, et al. Front Pharmacol. 2022 Jun 13;13:906452. doi: 10.3389/fphar.2022.906452. eCollection 2022. Front Pharmacol. 2022. PMID: 35770078 Free PMC article. - NLRP3 inflammasome in digestive diseases: From mechanism to therapy.
Qiang R, Li Y, Dai X, Lv W. Qiang R, et al. Front Immunol. 2022 Oct 26;13:978190. doi: 10.3389/fimmu.2022.978190. eCollection 2022. Front Immunol. 2022. PMID: 36389791 Free PMC article. Review. - Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y, Wang X. Yan F, et al. Front Cell Infect Microbiol. 2023 May 2;13:1152987. doi: 10.3389/fcimb.2023.1152987. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37201112 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous